Global Low Concentration Sulforaphane Market Growth 2026-2032

October 2026 | 102 pages | ID: G9E56047309EEN
LP Information

Abstracts

The global Low Concentration Sulforaphane market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Low Concentration Sulforaphane refers in this study to ingredients and formulations standardized to contain no more than 1% actual Sulforaphane by weight. These products generally consist of Sulforaphane dispersed in a botanical matrix or blended with carriers such as starches, maltodextrin, cyclodextrin or encapsulation materials to improve handling, dose accuracy and stability. Low Concentration Sulforaphane is supplied primarily as standardized powder, microencapsulated powder, premix or dilute liquid dispersion. Commercial quality is determined by verified Sulforaphane assay, blend uniformity, carrier composition, microbiological control, contaminant limits and retention of potency during shelf life. The segment supports dietary supplements, functional-food premixes, powdered beverages, gummies, tablets, capsules and selected personal-care formulations where small and accurately controlled active doses are required.

In 2025, global Low Concentration Sulforaphane production reached approximately 6511 kg, with an average global market price of around US$ 655 per kg.

Key Findings

Low Concentration Sulforaphane is defined in this study as products containing no more than 1% actual Sulforaphane

The segment improves dosing flexibility but increases carrier and logistics requirements per unit of active ingredient

One percent powder is a visible commercial specification for botanical and microencapsulated products

Assay sensitivity blend uniformity and stability are central quality-control requirements

Market Trends

The Low Concentration Sulforaphane segment is shifting from simple dilution of botanical extracts toward engineered premixes designed for uniformity and potency retention. Microencapsulation and carrier optimization are increasingly used to protect the active compound and improve compatibility with tablets, capsules, powders and dry beverage systems. Buyers are requesting clearer disclosure of carrier composition and actual Sulforaphane assay because low concentrations are especially vulnerable to analytical variability and labeling confusion. Customized concentrations are also becoming more common as contract manufacturers seek premixes matched to specific serving sizes. Over time, the segment is expected to develop from a commodity botanical-powder category into a formulation-service market in which stability, dispersibility and validated dose uniformity create greater value

Market Dynamics

Drivers

Low Concentration Sulforaphane is supported by demand for manageable dosing, simplified blending and lower active-material input per production batch. A standardized low-concentration premix can reduce weighing errors and improve distribution of Sulforaphane across large batches of capsules, tablets or powdered foods. The format is particularly useful where the intended dose is measured in milligrams rather than hundreds of milligrams. Natural botanical positioning and compatibility with conventional supplement manufacturing also support adoption. For smaller brands and contract manufacturers, purchasing a ready-to-use standardized premix may reduce formulation complexity compared with handling unstable high-purity Sulforaphane

Restraints

Low active concentration increases the volume of material required to deliver a given Sulforaphane dose, raising packaging, warehousing and transportation requirements per unit of active compound. Carrier ingredients can also limit formulation flexibility or conflict with clean-label positioning. At concentrations below 1%, inadequate mixing may produce significant capsule-to-capsule variation. Analytical measurement becomes more demanding because sampling error, matrix interference and degradation can materially affect reported results. The segment is also exposed to price comparison problems when products standardized to actual Sulforaphane are placed beside cheaper glucoraphanin-rich extracts marketed using similar terminology

Opportunities

Customized premixes offer opportunities in gummies, sachets, effervescent powders, nutrition bars, functional beverages and combination supplements. Suppliers can differentiate through water dispersibility, neutral flavor, low hygroscopicity, improved heat tolerance and compatibility with automated production lines. Microencapsulated 1% products may be especially attractive for brands seeking a balance between active-dose control and shelf-life protection. Further opportunities exist in private-label manufacturing, sports nutrition, pet nutrition and cosmetic premixes. Providing application testing and finished-product stability data can help suppliers capture more value than selling undifferentiated low-content botanical powder

Challenges

The major technical challenge is demonstrating that a low measured concentration represents stable, uniformly distributed Sulforaphane. Small absolute losses during production or storage can translate into a large percentage decline in declared potency. Representative sampling is difficult in heterogeneous botanical matrices, and different analytical methods may produce inconsistent results. Manufacturers must control particle size, carrier compatibility, moisture and mixing sequence. Commercially, the segment must overcome the perception that low concentration automatically means low quality. Clear specification design and cost-per-milligram comparisons are required to distinguish technically engineered premixes from weak or poorly standardized extracts

Industry Chain Analysis

Production begins with concentrated natural or synthesized Sulforaphane, which is standardized through controlled blending with botanical material or functional carriers. For natural products, upstream activities include broccoli-seed sourcing, glucoraphanin extraction, enzymatic conversion and purification. Midstream manufacturers dilute the active ingredient to the required specification, apply microencapsulation or complexation where necessary, and validate homogeneity through multiple-point sampling. Packaging must limit moisture, oxygen and heat exposure. Downstream users include supplement contract manufacturers, food premix companies, beverage developers and personal-care formulators. Value creation is concentrated in precise dilution, carrier selection, blend uniformity, shelf-life validation and application support rather than the nominal concentration alone

Segment Insights

Low Concentration Sulforaphane may be divided into basic standardized botanical powders, formulated carrier blends and microencapsulated products. Basic powders compete primarily on cost and botanical origin, while engineered blends provide better flowability and dosage control. Microencapsulated products represent the most technically differentiated direction because they address handling and stability limitations. Within the study boundary, 1% products are commercially visible, while lower specifications such as 0.1% can serve applications requiring very small active doses. The most attractive products combine a clearly defined assay with documented homogeneity and potency retention, enabling customers to calculate the true delivered dose

Downstream Market Opportunities

Capsules and tablets are the most straightforward applications because manufacturers can use Low Concentration Sulforaphane as a standardized premix within established production processes. Powder sachets and combination supplements provide additional opportunities where the carrier can contribute to blending performance. Gummies, beverages and food products offer larger potential volumes but expose Sulforaphane to moisture, temperature and sensory constraints. Cosmetic premixes may use low inclusion levels, although compatibility with emulsions and active-content stability must be demonstrated. Demand is expected to favor products customized for specific manufacturing processes rather than a single universal 1% powder

Regional Insights

China is an important manufacturing center for Low Concentration Sulforaphane, supported by botanical-extract production and availability of customizable 0.1%–1% specifications. North American demand is oriented toward finished supplements, private-label products and branded formulations requiring clear active-dose documentation. European opportunities depend heavily on ingredient status, intended use and national supplement rules, encouraging suppliers to provide detailed technical and regulatory files. Japan and other quality-sensitive Asia-Pacific markets offer potential for traceable microencapsulated ingredients with strict contaminant and stability specifications. Regional price differences are influenced by carrier systems, testing requirements and documentation rather than active concentration alone

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “Low Concentration Sulforaphane Industry Forecast” looks at past sales and reviews total world Low Concentration Sulforaphane sales in 2025, providing a comprehensive analysis by region and market sector of projected Low Concentration Sulforaphane sales for 2026 through 2032. With Low Concentration Sulforaphane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Low Concentration Sulforaphane industry.

This Insight Report provides a comprehensive analysis of the global Low Concentration Sulforaphane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Low Concentration Sulforaphane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Low Concentration Sulforaphane market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Low Concentration Sulforaphane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Low Concentration Sulforaphane.

This report presents a comprehensive overview, market shares, and growth opportunities of Low Concentration Sulforaphane market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

• Ultra-low Concentration Sulforaphane (?0.1%)
• General Low Concentration Sulforaphane (>0.1%–0.5%)
• Standard Low Concentration Sulforaphane (>0.5%–1.0%)

Segmentation by Stereochemical Composition:

• (R)-Sulforaphane
• (S)-Sulforaphane
• Racemic D,L-Sulforaphane

Segmentation by Source and Production Method:

• Plant-derived Enzymatic Hydrolysis Sulforaphane
• Bioconversion-derived Sulforaphane
• Chemically Synthesized Sulforaphane

Segmentation by Product Grade:

• Food and Nutraceutical-grade Sulforaphane
• Cosmetic-grade Sulforaphane
• Pharmaceutical Development-grade Sulforaphane
• Others

Segmentation by Application:

• Dietary Supplements and Nutraceuticals
• Pharmaceutical Development and Clinical Research
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Olga (INGOOD by Olga)
• CS Health
• Mara Labs
• Nutramax Laboratories Consumer Care
• Brassica Protection Products
• Blue California
• Pioneer Herb Industrial
• Fushan Biotech
• Xi'an Sost Biotech

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Low Concentration Sulforaphane market?
• What factors are driving Low Concentration Sulforaphane market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Low Concentration Sulforaphane market opportunities vary by end market size?
• How does Low Concentration Sulforaphane break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Low Concentration Sulforaphane Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Low Concentration Sulforaphane by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Low Concentration Sulforaphane by Country/Region, 2021, 2025 & 2032
2.2 Low Concentration Sulforaphane Segment by Type
  2.2.1 Ultra-low Concentration Sulforaphane (?0.1%)
  2.2.2 General Low Concentration Sulforaphane (>0.1%–0.5%)
  2.2.3 Standard Low Concentration Sulforaphane (>0.5%–1.0%)
  2.2.4 Low Concentration Sulforaphane Sales by Type
    2.2.4.1 Global Low Concentration Sulforaphane Sales Market Share by Type (2021-2026)
    2.2.4.2 Global Low Concentration Sulforaphane Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global Low Concentration Sulforaphane Sale Price by Type (2021-2026)
2.3 Low Concentration Sulforaphane Segment by Stereochemical Composition
  2.3.1 (R)-Sulforaphane
  2.3.2 (S)-Sulforaphane
  2.3.3 Racemic D,L-Sulforaphane
  2.3.4 Low Concentration Sulforaphane Sales by Stereochemical Composition
    2.3.4.1 Global Low Concentration Sulforaphane Sales Market Share by Stereochemical Composition (2021-2026)
    2.3.4.2 Global Low Concentration Sulforaphane Revenue and Market Share by Stereochemical Composition (2021-2026)
    2.3.4.3 Global Low Concentration Sulforaphane Sale Price by Stereochemical Composition (2021-2026)
2.4 Low Concentration Sulforaphane Segment by Source and Production Method
  2.4.1 Plant-derived Enzymatic Hydrolysis Sulforaphane
  2.4.2 Bioconversion-derived Sulforaphane
  2.4.3 Chemically Synthesized Sulforaphane
  2.4.4 Low Concentration Sulforaphane Sales by Source and Production Method
    2.4.4.1 Global Low Concentration Sulforaphane Sales Market Share by Source and Production Method (2021-2026)
    2.4.4.2 Global Low Concentration Sulforaphane Revenue and Market Share by Source and Production Method (2021-2026)
    2.4.4.3 Global Low Concentration Sulforaphane Sale Price by Source and Production Method (2021-2026)
2.5 Low Concentration Sulforaphane Segment by Product Grade
  2.5.1 Food and Nutraceutical-grade Sulforaphane
  2.5.2 Cosmetic-grade Sulforaphane
  2.5.3 Pharmaceutical Development-grade Sulforaphane
  2.5.4 Others
  2.5.5 Low Concentration Sulforaphane Sales by Product Grade
    2.5.5.1 Global Low Concentration Sulforaphane Sales Market Share by Product Grade (2021-2026)
    2.5.5.2 Global Low Concentration Sulforaphane Revenue and Market Share by Product Grade (2021-2026)
    2.5.5.3 Global Low Concentration Sulforaphane Sale Price by Product Grade (2021-2026)
2.6 Low Concentration Sulforaphane Segment by Application
  2.6.1 Dietary Supplements and Nutraceuticals
  2.6.2 Pharmaceutical Development and Clinical Research
  2.6.3 Others
  2.6.4 Low Concentration Sulforaphane Sales by Application
    2.6.4.1 Global Low Concentration Sulforaphane Sale Market Share by Application (2021-2026)
    2.6.4.2 Global Low Concentration Sulforaphane Revenue and Market Share by Application (2021-2026)
    2.6.4.3 Global Low Concentration Sulforaphane Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Low Concentration Sulforaphane Breakdown Data by Company
  3.1.1 Global Low Concentration Sulforaphane Annual Sales by Company (2021-2026)
  3.1.2 Global Low Concentration Sulforaphane Sales Market Share by Company (2021-2026)
3.2 Global Low Concentration Sulforaphane Annual Revenue by Company (2021-2026)
  3.2.1 Global Low Concentration Sulforaphane Revenue by Company (2021-2026)
  3.2.2 Global Low Concentration Sulforaphane Revenue Market Share by Company (2021-2026)
3.3 Global Low Concentration Sulforaphane Sale Price by Company
3.4 Key Manufacturers Low Concentration Sulforaphane Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Low Concentration Sulforaphane Product Location Distribution
  3.4.2 Players Low Concentration Sulforaphane Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR LOW CONCENTRATION SULFORAPHANE BY GEOGRAPHIC REGION

4.1 World Historic Low Concentration Sulforaphane Market Size by Geographic Region (2021-2026)
  4.1.1 Global Low Concentration Sulforaphane Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Low Concentration Sulforaphane Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Low Concentration Sulforaphane Market Size by Country/Region (2021-2026)
  4.2.1 Global Low Concentration Sulforaphane Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Low Concentration Sulforaphane Annual Revenue by Country/Region (2021-2026)
4.3 Americas Low Concentration Sulforaphane Sales Growth
4.4 APAC Low Concentration Sulforaphane Sales Growth
4.5 Europe Low Concentration Sulforaphane Sales Growth
4.6 Middle East & Africa Low Concentration Sulforaphane Sales Growth

5 AMERICAS

5.1 Americas Low Concentration Sulforaphane Sales by Country
  5.1.1 Americas Low Concentration Sulforaphane Sales by Country (2021-2026)
  5.1.2 Americas Low Concentration Sulforaphane Revenue by Country (2021-2026)
5.2 Americas Low Concentration Sulforaphane Sales by Type (2021-2026)
5.3 Americas Low Concentration Sulforaphane Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Low Concentration Sulforaphane Sales by Region
  6.1.1 APAC Low Concentration Sulforaphane Sales by Region (2021-2026)
  6.1.2 APAC Low Concentration Sulforaphane Revenue by Region (2021-2026)
6.2 APAC Low Concentration Sulforaphane Sales by Type (2021-2026)
6.3 APAC Low Concentration Sulforaphane Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Low Concentration Sulforaphane by Country
  7.1.1 Europe Low Concentration Sulforaphane Sales by Country (2021-2026)
  7.1.2 Europe Low Concentration Sulforaphane Revenue by Country (2021-2026)
7.2 Europe Low Concentration Sulforaphane Sales by Type (2021-2026)
7.3 Europe Low Concentration Sulforaphane Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Low Concentration Sulforaphane by Country
  8.1.1 Middle East & Africa Low Concentration Sulforaphane Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Low Concentration Sulforaphane Revenue by Country (2021-2026)
8.2 Middle East & Africa Low Concentration Sulforaphane Sales by Type (2021-2026)
8.3 Middle East & Africa Low Concentration Sulforaphane Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Low Concentration Sulforaphane
10.3 Manufacturing Process Analysis of Low Concentration Sulforaphane
10.4 Industry Chain Structure of Low Concentration Sulforaphane

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Low Concentration Sulforaphane Distributors
11.3 Low Concentration Sulforaphane Customer

12 WORLD FORECAST REVIEW FOR LOW CONCENTRATION SULFORAPHANE BY GEOGRAPHIC REGION

12.1 Global Low Concentration Sulforaphane Market Size Forecast by Region
  12.1.1 Global Low Concentration Sulforaphane Forecast by Region (2027-2032)
  12.1.2 Global Low Concentration Sulforaphane Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Low Concentration Sulforaphane Forecast by Type (2027-2032)
12.7 Global Low Concentration Sulforaphane Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Olga (INGOOD by Olga)
  13.1.1 Olga (INGOOD by Olga) Company Information
  13.1.2 Olga (INGOOD by Olga) Low Concentration Sulforaphane Product Portfolios and Specifications
  13.1.3 Olga (INGOOD by Olga) Low Concentration Sulforaphane Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Olga (INGOOD by Olga) Main Business Overview
  13.1.5 Olga (INGOOD by Olga) Latest Developments
13.2 CS Health
  13.2.1 CS Health Company Information
  13.2.2 CS Health Low Concentration Sulforaphane Product Portfolios and Specifications
  13.2.3 CS Health Low Concentration Sulforaphane Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 CS Health Main Business Overview
  13.2.5 CS Health Latest Developments
13.3 Mara Labs
  13.3.1 Mara Labs Company Information
  13.3.2 Mara Labs Low Concentration Sulforaphane Product Portfolios and Specifications
  13.3.3 Mara Labs Low Concentration Sulforaphane Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Mara Labs Main Business Overview
  13.3.5 Mara Labs Latest Developments
13.4 Nutramax Laboratories Consumer Care
  13.4.1 Nutramax Laboratories Consumer Care Company Information
  13.4.2 Nutramax Laboratories Consumer Care Low Concentration Sulforaphane Product Portfolios and Specifications
  13.4.3 Nutramax Laboratories Consumer Care Low Concentration Sulforaphane Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Nutramax Laboratories Consumer Care Main Business Overview
  13.4.5 Nutramax Laboratories Consumer Care Latest Developments
13.5 Brassica Protection Products
  13.5.1 Brassica Protection Products Company Information
  13.5.2 Brassica Protection Products Low Concentration Sulforaphane Product Portfolios and Specifications
  13.5.3 Brassica Protection Products Low Concentration Sulforaphane Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Brassica Protection Products Main Business Overview
  13.5.5 Brassica Protection Products Latest Developments
13.6 Blue California
  13.6.1 Blue California Company Information
  13.6.2 Blue California Low Concentration Sulforaphane Product Portfolios and Specifications
  13.6.3 Blue California Low Concentration Sulforaphane Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Blue California Main Business Overview
  13.6.5 Blue California Latest Developments
13.7 Pioneer Herb Industrial
  13.7.1 Pioneer Herb Industrial Company Information
  13.7.2 Pioneer Herb Industrial Low Concentration Sulforaphane Product Portfolios and Specifications
  13.7.3 Pioneer Herb Industrial Low Concentration Sulforaphane Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Pioneer Herb Industrial Main Business Overview
  13.7.5 Pioneer Herb Industrial Latest Developments
13.8 Fushan Biotech
  13.8.1 Fushan Biotech Company Information
  13.8.2 Fushan Biotech Low Concentration Sulforaphane Product Portfolios and Specifications
  13.8.3 Fushan Biotech Low Concentration Sulforaphane Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Fushan Biotech Main Business Overview
  13.8.5 Fushan Biotech Latest Developments
13.9 Xi'an Sost Biotech
  13.9.1 Xi'an Sost Biotech Company Information
  13.9.2 Xi'an Sost Biotech Low Concentration Sulforaphane Product Portfolios and Specifications
  13.9.3 Xi'an Sost Biotech Low Concentration Sulforaphane Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Xi'an Sost Biotech Main Business Overview
  13.9.5 Xi'an Sost Biotech Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Low Concentration Sulforaphane Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Low Concentration Sulforaphane Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Ultra-low Concentration Sulforaphane (?0.1%)
Table 4. Major Players of General Low Concentration Sulforaphane (>0.1%–0.5%)
Table 5. Major Players of Standard Low Concentration Sulforaphane (>0.5%–1.0%)
Table 6. Global Low Concentration Sulforaphane Sales by Type (2021-2026) & (kg)
Table 7. Global Low Concentration Sulforaphane Sales Market Share by Type (2021-2026)
Table 8. Global Low Concentration Sulforaphane Revenue by Type (2021-2026) & ($ million)
Table 9. Global Low Concentration Sulforaphane Revenue Market Share by Type (2021-2026)
Table 10. Global Low Concentration Sulforaphane Sale Price by Type (2021-2026) & (US$/kg)
Table 11. Major Players of (R)-Sulforaphane
Table 12. Major Players of (S)-Sulforaphane
Table 13. Major Players of Racemic D,L-Sulforaphane
Table 14. Global Low Concentration Sulforaphane Sales by Stereochemical Composition (2021-2026) & (kg)
Table 15. Global Low Concentration Sulforaphane Sales Market Share by Stereochemical Composition (2021-2026)
Table 16. Global Low Concentration Sulforaphane Revenue by Stereochemical Composition (2021-2026) & ($ million)
Table 17. Global Low Concentration Sulforaphane Revenue Market Share by Stereochemical Composition (2021-2026)
Table 18. Global Low Concentration Sulforaphane Sale Price by Stereochemical Composition (2021-2026) & (US$/kg)
Table 19. Major Players of Plant-derived Enzymatic Hydrolysis Sulforaphane
Table 20. Major Players of Bioconversion-derived Sulforaphane
Table 21. Major Players of Chemically Synthesized Sulforaphane
Table 22. Global Low Concentration Sulforaphane Sales by Source and Production Method (2021-2026) & (kg)
Table 23. Global Low Concentration Sulforaphane Sales Market Share by Source and Production Method (2021-2026)
Table 24. Global Low Concentration Sulforaphane Revenue by Source and Production Method (2021-2026) & ($ million)
Table 25. Global Low Concentration Sulforaphane Revenue Market Share by Source and Production Method (2021-2026)
Table 26. Global Low Concentration Sulforaphane Sale Price by Source and Production Method (2021-2026) & (US$/kg)
Table 27. Major Players of Food and Nutraceutical-grade Sulforaphane
Table 28. Major Players of Cosmetic-grade Sulforaphane
Table 29. Major Players of Pharmaceutical Development-grade Sulforaphane
Table 30. Major Players of Others
Table 31. Global Low Concentration Sulforaphane Sales by Product Grade (2021-2026) & (kg)
Table 32. Global Low Concentration Sulforaphane Sales Market Share by Product Grade (2021-2026)
Table 33. Global Low Concentration Sulforaphane Revenue by Product Grade (2021-2026) & ($ million)
Table 34. Global Low Concentration Sulforaphane Revenue Market Share by Product Grade (2021-2026)
Table 35. Global Low Concentration Sulforaphane Sale Price by Product Grade (2021-2026) & (US$/kg)
Table 36. Global Low Concentration Sulforaphane Sale by Application (2021-2026) & (kg)
Table 37. Global Low Concentration Sulforaphane Sale Market Share by Application (2021-2026)
Table 38. Global Low Concentration Sulforaphane Revenue by Application (2021-2026) & ($ million)
Table 39. Global Low Concentration Sulforaphane Revenue Market Share by Application (2021-2026)
Table 40. Global Low Concentration Sulforaphane Sale Price by Application (2021-2026) & (US$/kg)
Table 41. Global Low Concentration Sulforaphane Sales by Company (2021-2026) & (kg)
Table 42. Global Low Concentration Sulforaphane Sales Market Share by Company (2021-2026)
Table 43. Global Low Concentration Sulforaphane Revenue by Company (2021-2026) & ($ millions)
Table 44. Global Low Concentration Sulforaphane Revenue Market Share by Company (2021-2026)
Table 45. Global Low Concentration Sulforaphane Sale Price by Company (2021-2026) & (US$/kg)
Table 46. Key Manufacturers Low Concentration Sulforaphane Producing Area Distribution and Sales Area
Table 47. Players Low Concentration Sulforaphane Products Offered
Table 48. Low Concentration Sulforaphane Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 49. New Products and Potential Entrants
Table 50. Market M&A Activity & Strategy
Table 51. Global Low Concentration Sulforaphane Sales by Geographic Region (2021-2026) & (kg)
Table 52. Global Low Concentration Sulforaphane Sales Market Share Geographic Region (2021-2026)
Table 53. Global Low Concentration Sulforaphane Revenue by Geographic Region (2021-2026) & ($ millions)
Table 54. Global Low Concentration Sulforaphane Revenue Market Share by Geographic Region (2021-2026)
Table 55. Global Low Concentration Sulforaphane Sales by Country/Region (2021-2026) & (kg)
Table 56. Global Low Concentration Sulforaphane Sales Market Share by Country/Region (2021-2026)
Table 57. Global Low Concentration Sulforaphane Revenue by Country/Region (2021-2026) & ($ millions)
Table 58. Global Low Concentration Sulforaphane Revenue Market Share by Country/Region (2021-2026)
Table 59. Americas Low Concentration Sulforaphane Sales by Country (2021-2026) & (kg)
Table 60. Americas Low Concentration Sulforaphane Sales Market Share by Country (2021-2026)
Table 61. Americas Low Concentration Sulforaphane Revenue by Country (2021-2026) & ($ millions)
Table 62. Americas Low Concentration Sulforaphane Sales by Type (2021-2026) & (kg)
Table 63. Americas Low Concentration Sulforaphane Sales by Application (2021-2026) & (kg)
Table 64. APAC Low Concentration Sulforaphane Sales by Region (2021-2026) & (kg)
Table 65. APAC Low Concentration Sulforaphane Sales Market Share by Region (2021-2026)
Table 66. APAC Low Concentration Sulforaphane Revenue by Region (2021-2026) & ($ millions)
Table 67. APAC Low Concentration Sulforaphane Sales by Type (2021-2026) & (kg)
Table 68. APAC Low Concentration Sulforaphane Sales by Application (2021-2026) & (kg)
Table 69. Europe Low Concentration Sulforaphane Sales by Country (2021-2026) & (kg)
Table 70. Europe Low Concentration Sulforaphane Revenue by Country (2021-2026) & ($ millions)
Table 71. Europe Low Concentration Sulforaphane Sales by Type (2021-2026) & (kg)
Table 72. Europe Low Concentration Sulforaphane Sales by Application (2021-2026) & (kg)
Table 73. Middle East & Africa Low Concentration Sulforaphane Sales by Country (2021-2026) & (kg)
Table 74. Middle East & Africa Low Concentration Sulforaphane Revenue Market Share by Country (2021-2026)
Table 75. Middle East & Africa Low Concentration Sulforaphane Sales by Type (2021-2026) & (kg)
Table 76. Middle East & Africa Low Concentration Sulforaphane Sales by Application (2021-2026) & (kg)
Table 77. Key Market Drivers & Growth Opportunities of Low Concentration Sulforaphane
Table 78. Key Market Challenges & Risks of Low Concentration Sulforaphane
Table 79. Key Industry Trends of Low Concentration Sulforaphane
Table 80. Low Concentration Sulforaphane Raw Material
Table 81. Key Suppliers of Raw Materials
Table 82. Low Concentration Sulforaphane Distributors List
Table 83. Low Concentration Sulforaphane Customer List
Table 84. Global Low Concentration Sulforaphane Sales Forecast by Region (2027-2032) & (kg)
Table 85. Global Low Concentration Sulforaphane Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Americas Low Concentration Sulforaphane Sales Forecast by Country (2027-2032) & (kg)
Table 87. Americas Low Concentration Sulforaphane Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. APAC Low Concentration Sulforaphane Sales Forecast by Region (2027-2032) & (kg)
Table 89. APAC Low Concentration Sulforaphane Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 90. Europe Low Concentration Sulforaphane Sales Forecast by Country (2027-2032) & (kg)
Table 91. Europe Low Concentration Sulforaphane Revenue Forecast by Country (2027-2032) & ($ millions)
Table 92. Middle East & Africa Low Concentration Sulforaphane Sales Forecast by Country (2027-2032) & (kg)
Table 93. Middle East & Africa Low Concentration Sulforaphane Revenue Forecast by Country (2027-2032) & ($ millions)
Table 94. Global Low Concentration Sulforaphane Sales Forecast by Type (2027-2032) & (kg)
Table 95. Global Low Concentration Sulforaphane Revenue Forecast by Type (2027-2032) & ($ millions)
Table 96. Global Low Concentration Sulforaphane Sales Forecast by Application (2027-2032) & (kg)
Table 97. Global Low Concentration Sulforaphane Revenue Forecast by Application (2027-2032) & ($ millions)
Table 98. Olga (INGOOD by Olga) Basic Information, Low Concentration Sulforaphane Manufacturing Base, Sales Area and Its Competitors
Table 99. Olga (INGOOD by Olga) Low Concentration Sulforaphane Product Portfolios and Specifications
Table 100. Olga (INGOOD by Olga) Low Concentration Sulforaphane Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 101. Olga (INGOOD by Olga) Main Business
Table 102. Olga (INGOOD by Olga) Latest Developments
Table 103. CS Health Basic Information, Low Concentration Sulforaphane Manufacturing Base, Sales Area and Its Competitors
Table 104. CS Health Low Concentration Sulforaphane Product Portfolios and Specifications
Table 105. CS Health Low Concentration Sulforaphane Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 106. CS Health Main Business
Table 107. CS Health Latest Developments
Table 108. Mara Labs Basic Information, Low Concentration Sulforaphane Manufacturing Base, Sales Area and Its Competitors
Table 109. Mara Labs Low Concentration Sulforaphane Product Portfolios and Specifications
Table 110. Mara Labs Low Concentration Sulforaphane Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 111. Mara Labs Main Business
Table 112. Mara Labs Latest Developments
Table 113. Nutramax Laboratories Consumer Care Basic Information, Low Concentration Sulforaphane Manufacturing Base, Sales Area and Its Competitors
Table 114. Nutramax Laboratories Consumer Care Low Concentration Sulforaphane Product Portfolios and Specifications
Table 115. Nutramax Laboratories Consumer Care Low Concentration Sulforaphane Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 116. Nutramax Laboratories Consumer Care Main Business
Table 117. Nutramax Laboratories Consumer Care Latest Developments
Table 118. Brassica Protection Products Basic Information, Low Concentration Sulforaphane Manufacturing Base, Sales Area and Its Competitors
Table 119. Brassica Protection Products Low Concentration Sulforaphane Product Portfolios and Specifications
Table 120. Brassica Protection Products Low Concentration Sulforaphane Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 121. Brassica Protection Products Main Business
Table 122. Brassica Protection Products Latest Developments
Table 123. Blue California Basic Information, Low Concentration Sulforaphane Manufacturing Base, Sales Area and Its Competitors
Table 124. Blue California Low Concentration Sulforaphane Product Portfolios and Specifications
Table 125. Blue California Low Concentration Sulforaphane Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 126. Blue California Main Business
Table 127. Blue California Latest Developments
Table 128. Pioneer Herb Industrial Basic Information, Low Concentration Sulforaphane Manufacturing Base, Sales Area and Its Competitors
Table 129. Pioneer Herb Industrial Low Concentration Sulforaphane Product Portfolios and Specifications
Table 130. Pioneer Herb Industrial Low Concentration Sulforaphane Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 131. Pioneer Herb Industrial Main Business
Table 132. Pioneer Herb Industrial Latest Developments
Table 133. Fushan Biotech Basic Information, Low Concentration Sulforaphane Manufacturing Base, Sales Area and Its Competitors
Table 134. Fushan Biotech Low Concentration Sulforaphane Product Portfolios and Specifications
Table 135. Fushan Biotech Low Concentration Sulforaphane Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 136. Fushan Biotech Main Business
Table 137. Fushan Biotech Latest Developments
Table 138. Xi'an Sost Biotech Basic Information, Low Concentration Sulforaphane Manufacturing Base, Sales Area and Its Competitors
Table 139. Xi'an Sost Biotech Low Concentration Sulforaphane Product Portfolios and Specifications
Table 140. Xi'an Sost Biotech Low Concentration Sulforaphane Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 141. Xi'an Sost Biotech Main Business
Table 142. Xi'an Sost Biotech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Low Concentration Sulforaphane
Figure 2. Low Concentration Sulforaphane Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Low Concentration Sulforaphane Sales Growth Rate 2021-2032 (kg)
Figure 7. Global Low Concentration Sulforaphane Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Low Concentration Sulforaphane Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Low Concentration Sulforaphane Sales Market Share by Country/Region (2025)
Figure 10. Low Concentration Sulforaphane Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Ultra-low Concentration Sulforaphane (?0.1%)
Figure 12. Product Picture of General Low Concentration Sulforaphane (>0.1%–0.5%)
Figure 13. Product Picture of Standard Low Concentration Sulforaphane (>0.5%–1.0%)
Figure 14. Global Low Concentration Sulforaphane Sales Market Share by Type in 2026
Figure 15. Global Low Concentration Sulforaphane Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of (R)-Sulforaphane
Figure 17. Product Picture of (S)-Sulforaphane
Figure 18. Product Picture of Racemic D,L-Sulforaphane
Figure 19. Global Low Concentration Sulforaphane Sales Market Share by Stereochemical Composition in 2026
Figure 20. Global Low Concentration Sulforaphane Revenue Market Share by Stereochemical Composition (2021-2026)
Figure 21. Product Picture of Plant-derived Enzymatic Hydrolysis Sulforaphane
Figure 22. Product Picture of Bioconversion-derived Sulforaphane
Figure 23. Product Picture of Chemically Synthesized Sulforaphane
Figure 24. Global Low Concentration Sulforaphane Sales Market Share by Source and Production Method in 2026
Figure 25. Global Low Concentration Sulforaphane Revenue Market Share by Source and Production Method (2021-2026)
Figure 26. Product Picture of Food and Nutraceutical-grade Sulforaphane
Figure 27. Product Picture of Cosmetic-grade Sulforaphane
Figure 28. Product Picture of Pharmaceutical Development-grade Sulforaphane
Figure 29. Product Picture of Others
Figure 30. Global Low Concentration Sulforaphane Sales Market Share by Product Grade in 2026
Figure 31. Global Low Concentration Sulforaphane Revenue Market Share by Product Grade (2021-2026)
Figure 32. Low Concentration Sulforaphane Consumed in Dietary Supplements and Nutraceuticals
Figure 33. Global Low Concentration Sulforaphane Market: Dietary Supplements and Nutraceuticals (2021-2026) & (kg)
Figure 34. Low Concentration Sulforaphane Consumed in Pharmaceutical Development and Clinical Research
Figure 35. Global Low Concentration Sulforaphane Market: Pharmaceutical Development and Clinical Research (2021-2026) & (kg)
Figure 36. Low Concentration Sulforaphane Consumed in Others
Figure 37. Global Low Concentration Sulforaphane Market: Others (2021-2026) & (kg)
Figure 38. Global Low Concentration Sulforaphane Sale Market Share by Application (2025)
Figure 39. Global Low Concentration Sulforaphane Revenue Market Share by Application in 2025
Figure 40. Low Concentration Sulforaphane Sales by Company in 2025 (kg)
Figure 41. Global Low Concentration Sulforaphane Sales Market Share by Company in 2025
Figure 42. Low Concentration Sulforaphane Revenue by Company in 2025 ($ millions)
Figure 43. Global Low Concentration Sulforaphane Revenue Market Share by Company in 2025
Figure 44. Global Low Concentration Sulforaphane Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Low Concentration Sulforaphane Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Low Concentration Sulforaphane Sales 2021-2026 (kg)
Figure 47. Americas Low Concentration Sulforaphane Revenue 2021-2026 ($ millions)
Figure 48. APAC Low Concentration Sulforaphane Sales 2021-2026 (kg)
Figure 49. APAC Low Concentration Sulforaphane Revenue 2021-2026 ($ millions)
Figure 50. Europe Low Concentration Sulforaphane Sales 2021-2026 (kg)
Figure 51. Europe Low Concentration Sulforaphane Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Low Concentration Sulforaphane Sales 2021-2026 (kg)
Figure 53. Middle East & Africa Low Concentration Sulforaphane Revenue 2021-2026 ($ millions)
Figure 54. Americas Low Concentration Sulforaphane Sales Market Share by Country in 2025
Figure 55. Americas Low Concentration Sulforaphane Revenue Market Share by Country (2021-2026)
Figure 56. Americas Low Concentration Sulforaphane Sales Market Share by Type (2021-2026)
Figure 57. Americas Low Concentration Sulforaphane Sales Market Share by Application (2021-2026)
Figure 58. United States Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Low Concentration Sulforaphane Sales Market Share by Region in 2025
Figure 63. APAC Low Concentration Sulforaphane Revenue Market Share by Region (2021-2026)
Figure 64. APAC Low Concentration Sulforaphane Sales Market Share by Type (2021-2026)
Figure 65. APAC Low Concentration Sulforaphane Sales Market Share by Application (2021-2026)
Figure 66. China Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 70. India Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Low Concentration Sulforaphane Sales Market Share by Country in 2025
Figure 74. Europe Low Concentration Sulforaphane Revenue Market Share by Country (2021-2026)
Figure 75. Europe Low Concentration Sulforaphane Sales Market Share by Type (2021-2026)
Figure 76. Europe Low Concentration Sulforaphane Sales Market Share by Application (2021-2026)
Figure 77. Germany Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 78. France Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Low Concentration Sulforaphane Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Low Concentration Sulforaphane Sales Market Share by Type (2021-2026)
Figure 84. Middle East & Africa Low Concentration Sulforaphane Sales Market Share by Application (2021-2026)
Figure 85. Egypt Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Low Concentration Sulforaphane Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Low Concentration Sulforaphane in 2026
Figure 91. Manufacturing Process Analysis of Low Concentration Sulforaphane
Figure 92. Industry Chain Structure of Low Concentration Sulforaphane
Figure 93. Channels of Distribution
Figure 94. Global Low Concentration Sulforaphane Sales Market Forecast by Region (2027-2032)
Figure 95. Global Low Concentration Sulforaphane Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Low Concentration Sulforaphane Sales Market Share Forecast by Type (2027-2032)
Figure 97. Global Low Concentration Sulforaphane Revenue Market Share Forecast by Type (2027-2032)
Figure 98. Global Low Concentration Sulforaphane Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Low Concentration Sulforaphane Revenue Market Share Forecast by Application (2027-2032)